METHOD AND DEVICE FOR DETECTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 USING MXA PROTEINS

摘要

A multi-tiered, diagnostic strategy incorporating: a rapid host immune response assay as an initial screening test; a rapid immunoglobulin M, immunoglobulin G and/or immunoglobulin A test; and molecular confirmatory testing, for example via real-time reverse transcription polymerase chain reaction is used for confirmation of SARS-CoV-2. The rapid host immune response assay provides information for early screening and triage of patients with symptoms. The rapid immunoglobulin testing is used to assess which patients would benefit from quarantine or further testing and provide information on population exposure/herd immunity and determines if the patient's body is responding to a viral or bacterial infection. The strategy provides both a comprehensive screening and diagnostic testing strategy. The ability to triage patients within minutes rather than hours or days is a critical component to pandemic response.